Cargando…

Vaccination contre la COVID-19 dans les officines en région Auvergne-Rhône-Alpes. Étude menée trois mois après le début de la vaccination

INTRODUCTION: The development of vaccines against SARS-Cov-2 has enabled the deployment of vaccination, particularly through dispensing pharmacists, who are already authorised to administer influenza vaccines in France. METHODS: We surveyed pharmacists in the Auvergne-Rhône-Alpes region to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Boulliat, C., Malachane, A.-S., Massoubre, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378064/
https://www.ncbi.nlm.nih.gov/pubmed/34425077
http://dx.doi.org/10.1016/j.pharma.2021.08.004
_version_ 1783740762989527040
author Boulliat, C.
Malachane, A.-S.
Massoubre, B.
author_facet Boulliat, C.
Malachane, A.-S.
Massoubre, B.
author_sort Boulliat, C.
collection PubMed
description INTRODUCTION: The development of vaccines against SARS-Cov-2 has enabled the deployment of vaccination, particularly through dispensing pharmacists, who are already authorised to administer influenza vaccines in France. METHODS: We surveyed pharmacists in the Auvergne-Rhône-Alpes region to assess the current status of SARS-Cov-19 vaccination in the region. A questionnaire was sent to them; the analysis was carried out jointly with the URPS-Pharmacists. RESULTS: 739 pharmacies took part in our survey, and gave us their impressions of the organisation of the anti-COVID-19 vaccination and the information to be transmitted to patients. CONCLUSIONS: The commitment of pharmacists to the anti-COVID-19 vaccination testifies to the attachment of pharmacists to their patients, and their privileged place in prevention in France. The extension of their competences to the general vaccination of the population expects legitimacy from the decision-making authorities.
format Online
Article
Text
id pubmed-8378064
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Académie Nationale de Pharmacie. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-83780642021-08-20 Vaccination contre la COVID-19 dans les officines en région Auvergne-Rhône-Alpes. Étude menée trois mois après le début de la vaccination Boulliat, C. Malachane, A.-S. Massoubre, B. Ann Pharm Fr Article Original INTRODUCTION: The development of vaccines against SARS-Cov-2 has enabled the deployment of vaccination, particularly through dispensing pharmacists, who are already authorised to administer influenza vaccines in France. METHODS: We surveyed pharmacists in the Auvergne-Rhône-Alpes region to assess the current status of SARS-Cov-19 vaccination in the region. A questionnaire was sent to them; the analysis was carried out jointly with the URPS-Pharmacists. RESULTS: 739 pharmacies took part in our survey, and gave us their impressions of the organisation of the anti-COVID-19 vaccination and the information to be transmitted to patients. CONCLUSIONS: The commitment of pharmacists to the anti-COVID-19 vaccination testifies to the attachment of pharmacists to their patients, and their privileged place in prevention in France. The extension of their competences to the general vaccination of the population expects legitimacy from the decision-making authorities. Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. 2021-08-20 /pmc/articles/PMC8378064/ /pubmed/34425077 http://dx.doi.org/10.1016/j.pharma.2021.08.004 Text en © 2021 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article Original
Boulliat, C.
Malachane, A.-S.
Massoubre, B.
Vaccination contre la COVID-19 dans les officines en région Auvergne-Rhône-Alpes. Étude menée trois mois après le début de la vaccination
title Vaccination contre la COVID-19 dans les officines en région Auvergne-Rhône-Alpes. Étude menée trois mois après le début de la vaccination
title_full Vaccination contre la COVID-19 dans les officines en région Auvergne-Rhône-Alpes. Étude menée trois mois après le début de la vaccination
title_fullStr Vaccination contre la COVID-19 dans les officines en région Auvergne-Rhône-Alpes. Étude menée trois mois après le début de la vaccination
title_full_unstemmed Vaccination contre la COVID-19 dans les officines en région Auvergne-Rhône-Alpes. Étude menée trois mois après le début de la vaccination
title_short Vaccination contre la COVID-19 dans les officines en région Auvergne-Rhône-Alpes. Étude menée trois mois après le début de la vaccination
title_sort vaccination contre la covid-19 dans les officines en région auvergne-rhône-alpes. étude menée trois mois après le début de la vaccination
topic Article Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378064/
https://www.ncbi.nlm.nih.gov/pubmed/34425077
http://dx.doi.org/10.1016/j.pharma.2021.08.004
work_keys_str_mv AT boulliatc vaccinationcontrelacovid19danslesofficinesenregionauvergnerhonealpesetudemeneetroismoisapresledebutdelavaccination
AT malachaneas vaccinationcontrelacovid19danslesofficinesenregionauvergnerhonealpesetudemeneetroismoisapresledebutdelavaccination
AT massoubreb vaccinationcontrelacovid19danslesofficinesenregionauvergnerhonealpesetudemeneetroismoisapresledebutdelavaccination